RecruitingCheek WrinklesMenopausal Women
A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages
Eligible age
22+ yrs
Accepts
Women
Locations
2 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
To assess protein expression stimulated by poly L-lactic acid (PLLA) via punch biopsy at each follow-up visits compared to Baseline.
Sponsor: Galderma R&D
You may qualify if…
- ✓ Subjects diagnosed with symmetrical, moderate-to-severe cheek wrinkles on each side of the face as assessed via the Galderma Cheek Wrinkles Scale.
- ✓ Subject with intent to undergo correction of cheek augmentation or contour deficiencies
- ✓ Subjects willing to have a 3-mm punch biopsy on each preauricular side
- ✓ Subjects willing to maintain the current lifestyle, daily routine (e.g., diet, exercise, sleep, etc.), and a stable Body Mass Index (BMI, ± 5 kg/m2) throughout the study
- ✓ Ability of giving consent for participation in the study.
- ✓ Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments.
You may not qualify if…
- ✕ Subjects with asymmetrical severity or unidentical cheek wrinkle score between 2 sides of the cheek.
- ✕ Subjects with a history of allergy or hypersensitivity to any ingredient of the treatment products.
- ✕ Previous tissue-augmenting therapy, contouring, or revitalization treatment in the face, except lips.
- ✕ Previous treatment/procedure in the face in the previous 6 months that, in the Investigator's opinion, would interfere with the study injections and/or study assessments or exposed the study subject to undue risk by study participation, or planning to undergo any of these procedures affecting the treatment area at any time during the study.
- ✕ Subjects with any medical condition that, in the opinion of the Investigator, would make the subject unsuitable for inclusion.
Where it's recruiting
Source: ClinicalTrials.gov · NCT07342400 · last updated 2026-01-15